These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 1730513
21. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line. Heiss P, Bermatz S, Wehnes H, Heinzmann U, Senekowitsch-Schmidtke R. Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622 [Abstract] [Full Text] [Related]
22. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma. Hersey P. Cancer Treat Res; 1991; 54():137-51. PubMed ID: 1673856 [Abstract] [Full Text] [Related]
23. Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography-tandem mass spectrometry. Kaneko T, Okita H, Nakajima H, Iijima K, Ogasawara N, Miyagawa Y, Katagiri YU, Nakagawa A, Kiyokawa N, Sato T, Fujimoto J. Int J Oncol; 2010 Nov; 37(5):1279-88. PubMed ID: 20878075 [Abstract] [Full Text] [Related]
24. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies. Kusano A, Ohta S, Shitara K, Hanai N. Anticancer Res; 1993 Nov; 13(6A):2207-12. PubMed ID: 8297135 [Abstract] [Full Text] [Related]
25. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Ozawa H, Kotani M, Kawashima I, Tai T. Biochim Biophys Acta; 1992 Jan 24; 1123(2):184-90. PubMed ID: 1371229 [Abstract] [Full Text] [Related]
26. The 3G11+ antigen, a marker for murine CD4+ TH1 lymphocytes, is a ganglioside. Greer JM, Koerner TA, Hayakawa K, Hardy RR, Kemp JD. Glycobiology; 1993 Aug 24; 3(4):391-401. PubMed ID: 7691279 [Abstract] [Full Text] [Related]
27. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Cheung NK, Modak S. Clin Cancer Res; 2002 May 24; 8(5):1217-23. PubMed ID: 12006541 [Abstract] [Full Text] [Related]
28. Differential expression of gangliosides and galactolipids in fetal human oligodendrocytes and astrocytes in culture. Satoh JI, Tai T, Kim SU. Brain Res Dev Brain Res; 1996 May 31; 93(1-2):172-81. PubMed ID: 8804704 [Abstract] [Full Text] [Related]
29. Analysis of gangliosides from carp intestinal mucosa. Irie T, Watarai S, Kushi Y, Kasama T, Kodama H. Fish Shellfish Immunol; 2004 Feb 31; 16(2):117-25. PubMed ID: 15123316 [Abstract] [Full Text] [Related]
31. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO. Cancer Res; 1989 Jan 01; 49(1):191-6. PubMed ID: 2908845 [Abstract] [Full Text] [Related]
35. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns. Ruan S, Lloyd KO. Cancer Res; 1992 Oct 15; 52(20):5725-31. PubMed ID: 1394196 [Abstract] [Full Text] [Related]
36. Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2. Patel K, Rossell RJ, Pemberton LF, Cheung NK, Walsh FS, Moore SE, Sugimoto T, Kemshead JT. Br J Cancer; 1989 Dec 15; 60(6):861-6. PubMed ID: 2481486 [Abstract] [Full Text] [Related]
37. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses. Bolesta E, Kowalczyk A, Wierzbicki A, Rotkiewicz P, Bambach B, Tsao CY, Horwacik I, Kolinski A, Rokita H, Brecher M, Wang X, Ferrone S, Kozbor D. Cancer Res; 2005 Apr 15; 65(8):3410-8. PubMed ID: 15833876 [Abstract] [Full Text] [Related]
38. Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases. Zhang H, Zhang S, Cheung NK, Ragupathi G, Livingston PO. Cancer Res; 1998 Jul 01; 58(13):2844-9. PubMed ID: 9661900 [Abstract] [Full Text] [Related]
39. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Vrionis FD, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD. Cancer Res; 1989 Dec 01; 49(23):6645-51. PubMed ID: 2479468 [Abstract] [Full Text] [Related]